Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1408, 2003-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Combined inflammatory mediator blockade effective in seasonal allergic rhinitis and asthma
Inpharma, Vol. 1, Iss. 1267, 2000-01 ,pp. :
Omalizumab attenuates early responses in allergic rhinitis
Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. :
Montelukast an advantage for asthma and allergic rhinitis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 518, 2006-01 ,pp. :
Omalizumab: a guide to its use in allergic asthma
Drugs & Therapy Perspectives, Vol. 24, Iss. 9, 2008-09 ,pp. :